Lung Cancer in Women: A Single Institution Experience with 50 Patients

Babacan, Nalan Akgul; Yucel, Birsen; Kilickap, Saadettin; Seker, Mehmet Metin; Kacan, Turgut; Olcas, Ilknur Koc; Eren, Ayfer Ay; Odabas, Hatice

추천

검색

자료유형: 학술저널

저자정보: Babacan, Nalan Akgul (Department of Medical Oncology, University of Cumhuriyet) Yucel, Birsen (Department of Radiation Oncology, University of Cumhuriyet) Kilickap, Saadettin (Department of Medical Oncology, SIVAS, University of Hacettepe) Seker, Mehmet Metin (Department of Medical Oncology, University of Cumhuriyet) Kacan, Turgut (Department of Medical Oncology, University of Cumhuriyet) Olcas, Ilknur Koc (Department of Internal Medicine, University of Cumhuriyet) Eren, Ayfer Ay (Department of Radiation Oncology, University of Cumhuriyet) Odabas, Hatice (Medical Oncology Department, Kartal Education and Research Hospital)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제1호

발행연도: 2014.1

수록면: 151 - 154 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Lung cancer is the most common cause of cancer-related death worldwide. The incidence of lung cancer is aproximately 7-8 thousand percent in Turkish women. In this study, we aimed to evaluate the clinical, pathological properties and survival data of female patients with lung cancer who were treated in our center. Materials and Methods: From 2007 to 2012, 50 women with lung cancer were enrolled. Patient data were evaluated retrospectively. Results: The median age was 61 (40-81). Forty patients (80%) were diagnosed with non small cell lung cancer (NSCLC), 10 patients (20%) were small cell carcinoma (SCC). Twelve (24%) patients were smokers and 13 of 16 non-smokers had a history of exposure to asbestos. The most common histologic subtype was adenocarcinoma (46%) and this accounted for 71% in patients with exposure to asbestos. The most common initial Eastern Cooperative Oncology Group (ECOG) performance score was 1 (24 patients, 48%) and initial stage was IV (25 patients, 50%) in the study group. During the median 15 months (1-96 months) followup period: 1 year overall survival (OS) was 68%, 2year overall survival was 36% and the median survival time was 19 months. According to univariate analysis, poor ECOG performance status, advanced stage, anemia and weight loss at time of diagnosis were negative prognostic factors. However, adenocarcinoma sub-type was a positive prognostic factor. Conclusions: In this study NSCLC sub-type, poor ECOG performance score, advanced stage, anemia and weight loss were prognostic factors in Turkish women with lung cancer.

#Chemotherapy #female gender #prognosis #lung cancer #survival #Turkey

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요